Huron Consulting Group Inc. $HURN Shares Sold by CenterBook Partners LP

CenterBook Partners LP reduced its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 76.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,635 shares of the business services provider’s stock after selling 22,044 shares during the quarter. CenterBook Partners LP’s holdings in Huron Consulting Group were worth $1,147,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of HURN. CWM LLC increased its stake in shares of Huron Consulting Group by 14.9% in the 4th quarter. CWM LLC now owns 464 shares of the business services provider’s stock valued at $80,000 after purchasing an additional 60 shares in the last quarter. California State Teachers Retirement System boosted its position in Huron Consulting Group by 0.5% during the second quarter. California State Teachers Retirement System now owns 16,396 shares of the business services provider’s stock worth $2,255,000 after purchasing an additional 76 shares in the last quarter. Truist Financial Corp grew its holdings in Huron Consulting Group by 1.4% in the fourth quarter. Truist Financial Corp now owns 6,485 shares of the business services provider’s stock valued at $1,121,000 after purchasing an additional 87 shares during the period. Clearstead Advisors LLC grew its stake in Huron Consulting Group by 86.2% in the 3rd quarter. Clearstead Advisors LLC now owns 203 shares of the business services provider’s stock valued at $30,000 after acquiring an additional 94 shares during the period. Finally, State of Wyoming grew its position in shares of Huron Consulting Group by 3.5% in the fourth quarter. State of Wyoming now owns 3,098 shares of the business services provider’s stock valued at $536,000 after purchasing an additional 105 shares during the period. 93.90% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Ekta Singh-Bushell sold 443 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $118.44, for a total transaction of $52,468.92. Following the completion of the sale, the director directly owned 13,646 shares in the company, valued at approximately $1,616,232.24. This trade represents a 3.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joy Brown sold 1,821 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $105.01, for a total transaction of $191,223.21. Following the sale, the director owned 8,575 shares of the company’s stock, valued at approximately $900,460.75. The trade was a 17.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,658 shares of company stock valued at $415,931 in the last ninety days. 2.07% of the stock is currently owned by company insiders.

Analyst Ratings Changes

HURN has been the subject of a number of recent research reports. Truist Financial reduced their target price on shares of Huron Consulting Group to $155.00 and set a “buy” rating for the company in a research report on Tuesday. Wall Street Zen cut shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a research report on Tuesday, May 12th. Wedbush reiterated an “outperform” rating and issued a $160.00 target price on shares of Huron Consulting Group in a research report on Wednesday, May 6th. Finally, Weiss Ratings cut shares of Huron Consulting Group from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday, May 12th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $184.25.

Huron Consulting Group Price Performance

Huron Consulting Group stock opened at $109.44 on Thursday. Huron Consulting Group Inc. has a 12-month low of $100.10 and a 12-month high of $186.77. The stock has a market cap of $1.77 billion, a P/E ratio of 18.68 and a beta of 0.08. The company has a 50-day moving average price of $118.32 and a 200 day moving average price of $144.07. The company has a current ratio of 2.22, a quick ratio of 2.22 and a debt-to-equity ratio of 2.10.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings data on Tuesday, May 5th. The business services provider reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.15. Huron Consulting Group had a net margin of 5.94% and a return on equity of 29.41%. The firm had revenue of $451.77 million during the quarter, compared to analysts’ expectations of $437.12 million. During the same period last year, the business earned $1.68 earnings per share. Huron Consulting Group’s revenue was up 12.1% compared to the same quarter last year. Huron Consulting Group has set its FY 2026 guidance at 8.350-9.150 EPS. Sell-side analysts anticipate that Huron Consulting Group Inc. will post 8.71 earnings per share for the current year.

About Huron Consulting Group

Huron Consulting Group (NASDAQ:HURN) is a global professional services firm that advises organizations across a range of industries on strategy, operations and technology. Founded in 2002 and headquartered in Chicago, the company helps clients address complex business challenges such as performance improvement, digital transformation and organizational change. Huron’s consultants work alongside executive leadership teams to develop and implement tailored solutions that drive growth, increase efficiency and manage risk.

Huron’s service offerings encompass business and financial advisory, healthcare performance improvement, life sciences consulting, higher education and research lifecycle support, as well as legal and regulatory consulting.